JohnRotrosenMD
Psychiatry • New York, NYProfessor, Psychiatry, New York University School of Medicine
Dr. Rotrosen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
423 East 23 St
Psychiatry VA Nyhhs
New York, NY 10010Phone+1 212-951-3294
Education & Training
NYU Grossman School of MedicineInternship, Transitional Year, 1973 - 1974- New York University School of MedicineClass of 1972
Certifications & Licensure
NY State Medical License 1976 - 2025- American Board of Psychiatry and Neurology Psychiatry
Clinical Trials
- Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 Start of enrollment: 1996 Apr 01
- Modeling Impaired Judgement in Cocaine Abusers - 6 Start of enrollment: 1997 Mar 01
- Prepulse Inhibition of Startle in Cocaine Dependence - 7 Start of enrollment: 1997 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 58 citationsA controlled assessment of propranolol in the treatment of neuroleptic-induced akathisia.Lenard A. Adler, Burt Angrist, Eric D. Peselow, June Corwin, Robert Maslansky
The British Journal of Psychiatry. 1986-07-01 - 426 citationsMisuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature.Timothy E. Wilens, Lenard A. Adler, Jill U Adams, Stephanie Sgambati, John Rotrosen
Journal of the American Academy of Child and Adolescent Psychiatry. 2008-01-01 - 47 citationsPharmacokinetics and Pharmacodynamics of Multiple Sublingual Buprenorphine Tablets in Dose‐Escalation TrialsDomenic A. Ciraulo, Robert Hitzemann, Eugene Somoza, Clifford M. Knapp, John Rotrosen
Journal of Clinical Pharmacology. 2006-02-01
Journal Articles
- Cost-Effectiveness of Buprenorphine–Naloxone Versus Extended-Release Naltrexone to Prevent Opioid RelapseJoshua D Lee, John Rotrosen, Edward V Nunes, Annals of Internal Medicine
- American Psychiatric Association PublishingJohn Rotrosen, MD, PubMed
Press Mentions
Open-Label Placebo Improved Outcomes for People in Treatment for Opioid Use DisorderApril 12th, 2023- Psychedelic Drug Therapy May Help Treat Alcohol AddictionAugust 24th, 2022
Study Shows Two Addiction Medications Similar but Drop Out Rates High: Three Possible RemediesNovember 27th, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
